← FDA Drug Approvals (Drugs@FDA)
RETACRIT
BLA · Biologics License Application · Sponsor: HOSPIRA INC · Approved 2018-05-15
Drug application
- FDA Application #
BLA125545- Application type
- Biologics License Application
- Brand name
- RETACRIT
- Generic name
- EPOETIN ALFA-EPBX
- Active ingredients
- EPOETIN ALFA-EPBX
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- HOSPIRA INC
- Manufacturer
- Vifor (International) Inc.
- First approval
- 2018-05-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown